Content Rheum | IL-17

top of page

Content Rheum

Interleukin-17 Inhibition

FAQs

Click a title to watch the FAQ

Describe the IL17-Induced Inflammatory Cascade

Provide immunologic rationale for IL17-directed therapy in PsA, AS, and nr-axSpA

How do you explain the timing of ixekizumab's clinical efficacy to patients?

Are IL-17 Inhibitors Efficacious in Treating the Nail-DIP Complex in PsA?

Medication Review_v2.png

MEDICATION REVIEWS

Click a title to watch the review

Describe The Mechanism of Action of Ixekizumab

What is the safety profile of ixekizumab in PsA and axSpA?

What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

JOURNAL CLUBS

Click a title to watch the journal club

Safety of Ixekizumab With or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study

A Head-To-Head Comparison of Ixekizumab Vs. Guselkumab In Patients With Moderate-To-Severe Plaque Psoriasis: 12-Week Efficacy, Safety And Speed Of Response From A Randomized, Double-Blinded Trial

PODCASTS

Click a title to watch the podcast

RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

Become a RhAPP Member

bottom of page